Researchers from Cardiff University have discovered a potential treatment for therapy-resistant breast cancer. Cardiff University reports its European Cancer Stem Cell Research Institute has repurposed a current cancer therapy, TRAIL, to find a new treatment for advanced cancers that are resistant to anti-hormone therapy. Up to 75% of women diagnosed with breast cancer will have … Continue reading Potential treatment of therapy-resistant breast cancer

Professor Peter Ghazal FMedSci has been appointed to lead Cardiff University’s Project Sepsis, a research collaboration focused on the development of a test to rapidly diagnose sepsis in extremely vulnerable populations such as babies and the very old. Cardiff University report their Vice-Chancellor, Professor Colin Riordan, said “I am delighted to welcome Professor Ghazal to … Continue reading Peter Ghazal to lead Project Sepsis

A new method to test the likelihood of a drug turning into a potentially harmful version of itself when it enters the body has been developed. Cardiff University reports their researchers, in collaboration with Liverpool John Moores University and AstraZeneca, have developed a simple approach to trawl through large databases of pharmaceutical drugs and assess … Continue reading Stopping a drug turning into a harmful version of itself

Drugs designed for the treatment of central nervous system diseases could also be used to prevent the development of injury induced arthritis, potentially saving the NHS around half a billion pounds a year. Dr Deborah Mason and Dr Cleo Bonnet at Cardiff University, who reported on the news, discovered that a single injection of a … Continue reading Common drugs could prevent osteoarthritis

Fight for Sight and Nystagmus Network have partnered to fund research aimed at the early detection of nystagmus and improve the quality of life of people with the condition. Nystagmus is a complex condition characterised by repeated involuntary movement of the eyes. Vision UK reports Dr Lee Mcilreavy from Cardiff University will use the funding … Continue reading Funding for research into nystagmus

Researchers at Cardiff University and the University of Dundee have identified a drug molecule within a medicine used to treat tapeworm infections which could lead to new treatments for patients with Parkinson’s disease. Parkinson’s disease is a long-term degenerative disorder of the central nervous system that, according to Parkinson’s UK, affects one person in every … Continue reading Tapeworm drug could treat Parkinson’s disease

Cardiff Metropolitan University has secured a grant to design an innovative sterilising device for medical equipment. Cardiff Metropolitan University report they have successfully secured funding to support an interdisciplinary collaboration arising from the Welsh Crucible programme that looks at the design and development of an innovative sterilising device for venous access ports (VAPs). The interdisciplinary … Continue reading Grant secured to design innovative sterilising device

Researchers at Cardiff University have discovered a new family of lipids that plays a key role in controlling clot formation. Cardiff University reports the new discovery could lead to novel ways of reducing the risk of excess clotting, called thrombosis, potentially preventing deaths from many killer diseases such as heart attacks, strokes and deep vein … Continue reading New family of lipids plays key role in clot formation

The Sir Geraint Evans Wales Heart Research Institute is to extend its ground breaking heart research to cover the wider health issues of cardiovascular disease, following extensive consultation with family members of the late Sir Geraint Evans, and leading academics at Cardiff University. Cardiovascular disease (CVD) is an umbrella term that describes all associated diseases … Continue reading Heart research centre renamed as it extends to cover CVD

Researchers at Cardiff University have found a way to boost the cancer destroying ability of the immune system’s T-cells, offering new hope in the fight against a wide range of cancers. Cardiff University reports the team, using CRISPR genome editing, took the genetic engineering of killer T-cells one step further by removing their non-cancer specific … Continue reading Improved method of engineering T-cells to attack cancer